Histopathological characterization of the skeletal myopathy in rasH2 mice carrying human prototype c-Ha-ras gene

Journal of Veterinary Medical Science

Volumn 67, Issue 5, 2005, Pages 481-489

  Tsuchiya, Takayuki ^a,b   Okada, Miyoko ^a   Sakairi, Tetsuya ^a   Sano, Fumiko ^a   Sugimoto, Jiro ^a   Takagi, Shirou ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^b BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Histopathology; rasH2 mouse; Skeletal myopathy

Indexed keywords

ANIMAL; ARTICLE; GENETICS; MALE; MOUSE; MUSCLE DISEASE; ONCOGENE RAS; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; TRANSGENIC ORGANISM; ULTRASTRUCTURE;

ANIMALS; GENES, RAS; MALE; MICE; MUSCLE, SKELETAL; MUSCULAR DISEASES; ORGANISMS, GENETICALLY MODIFIED;

EID: 20844451924     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.67.481     Document Type: Article

References (43)

1. Ashmore, C. R. and Doerr, L. 1971. Postnatal development of fiber types in normal and dystrophic skeletal muscle of the chick. Exp. Neurol. 30: 431-446.
2. Bittner, R. E., Anderson, L. V., Burkhardt, E., Bashir, R., Vafiadaki, E., Ivanova, S., Raffelsberger, T., Maerk, I., Hoger, H., Jung, M., Karbasiyan, M., Storch, M., Lassmann, H., Moss, J. A., Davison, K., Harrison, R., Bushby, K. M. and Reis, A. 1999. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat. Genet. 23: 141-142.
3. Bulfield, G., Siller, W. G., Wight, P. A. and Moore, K. J. 1984. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. U.S.A. 81: 1189-1192.
4. Carpenter, J. L., Hoffman, E. P., Romanul, F. C., Kunkel, L. M., Rosales, R. K., Ma, N. S., Dasbach, J. J., Rae, J. F., Moore, F. M., McAfee, M. B. and Pearce, L. K. 1989. Feline muscular dystrophy with dystrophin deficiency. Am. J. Pathol. 135: 909-919.
5. Cohn, R. D. and Campbell, K. P. 2000. Molecular basis of muscular dystrophies. Muscle. Nerve. 23: 1456-1471.
6. Cooper, B. J., Winand, N. J., Stedman, H., Valentine, B. A., Hoffman, E. P., Kunkel, L. M., Scott, M. O., Fischbeck, K. H., Kornegay, J. N., Avery, R. J., Williams, J. R., Schmickel, R. D. and Sylvester, J.E. 1988. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature (Lond.) 334: 154-156.
7. Cullen, M. J. and Jaros, E. 1988. Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy. Acta Neuropathol (Berl.) 77: 69-81.
8. Donald McGavin, M. 1991.Procedures for morphologic studies of skeletal muscle, rat, mouse, and hamster. pp. 101-108. In: Cardiovascular and Musculoskeletal Systems (Jones, T. C., Mohr, U. and Hunt, R. D. eds.), Springer-Verlag, Berlin.
9. Dowling, P., Culligan, K. and Ohlendieck, K. 2002. Distal mdx muscle groups exhibiting up-regulation of utrophin and rescue of dystrophin-associated glycoproteins exemplify a protected phenotype in muscular dystrophy. Naturwissenschaften 89: 75-78.
10. Dowling, P., Lohan, J. and Ohlendieck, K. 2003. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan. Eur. J. Cell. Biol. 82: 222-230.
11. Emery, A. E. 2002. The muscular dystrophies. Lancet 359: 687-695.
12. Engel, A. G. and Gomez, M. R. 1967. Nemaline (Z disk) myopathy: observations on the origin, structure, and solubility properties of the nemaline structures. J. Neuropathol. Exp. Neurol. 26: 601-619.
13. Gordon, E. S. and Hoffman, E. P. 2001. The ABC's of limb-girdle muscular dystrophy: alpha-sarcoglycanopathy, Bethlem myopathy, calpainopathy and more. Curr. Opin. Neurol. 14: 567-573.
14. Heffner, R. R. 1989. Muscle biopsy in neuromuscular disorders. pp. 119-139. In: Diagnostic Surgical Pathology (Sternberg, S. ed.), Raven Press Ltd., New York.
15. Hoffman, E. P. 2001. Dystrophinopathies. pp. 385-432. In: Disorders of Voluntary Muscle (Karpati, G., Hilton-Jones, D., Griggs, R. eds.), Cambridge Univ. Press, Cambridge, UK.
16. Hoffman, E. P. and Kunkel, L. M. 1989. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron 2: 1019-1029.
17. Homburger, F., Baker, J. R., Nixon, C. W. and Whitney, R. 1962. Primary, generalized polymyopathy and cardiac necrosis in an inbred line of Syrian hamsters. Med. Exp. 6: 339-345.
18. Meier, H. and Southard, J. L. 1970. Muscular dystrophy in the mouse caused by an allele at the dy-locus. Life. Sci. 9: 137-144.
19. Michelson, A. M., Russell, E. S. and Hoffman, P. J. 1955. Dystrophia muscularis: a hereditary primary myopathy in the house mouse. Proc. Natl. Acad. Sci. U. S. A. 41: 1079-1084.
20. Montgomery, C. A. 1978. Muscle diseases. pp. 821-887. In: Pathology of Laboratory Animals (Benirschke, K., Garner, F. and Jones, T. eds.), Springer-Verlag, New York.
21. Nigro, V., Okazaki, Y., Belsito, A., Piluso, G., Matsuda, Y., Politano, L., Nigro, G., Ventura, C., Abbondanza, C., Molinari, A. M., Acampora, D., Nishimura, M., Hayashizaki, Y. and Puca, G. A. 1997. Identification of the Syrian hamster cardiomyopathy gene. Hum. Mol. Genet. 6: 601-607.
22. Nonaka, I. 1994. Muscle pathologic diagnosis-mechanism in muscle fiber degeneration. Rinsho Shinkeigaku 34: 1279-1281 (in Japanese).
23. Nonaka, I. and Sugita, H. 1981. Intracytoplasmic vacuoles in alpha W fibers of dystrophic chicken muscle-probable early pathologic event initiates massive fiber necrosis. Acta Neuropathol. (Berl.) 55: 173-181.
24. Pagel, C. N. and Partridge, T. A. 1999. Covert persistence of mdx mouse myopathy is revealed by acute and chronic effects of irradiation. J. Neurol. Sci. 164: 103-116.
25. Palmucci, L., Schiffer, D., Monga, G., Mollo, F. and de Marchi, M. 1978. Central core disease: histochemical and ultrastructural study of muscle biopsies of father and daughter. J. Neurol. 218: 55-62.
26. Porter, J. D. 1998. Commentary: extraocular muscle sparing in muscular dystrophy: a critical evaluation of potential protective mechanisms. Neuromuscul. Disord. 8: 198-203.
27. Porter, J. D., Rafael, J. A., Ragusa, R. J., Brueckner, J. K., Trickett, J. I. and Davies, K. E. 1998. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. J. Cell. Sci. 111 (Pt 13): 1801-1811.
28. Porter, J. D., Merriam, A. P., Leahy, P., Gong, B., Feuerman, J., Cheng, G. and Khanna, S. 2004. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Hum. Mol. Genet. 13: 257-269.
29. Robinson, D. 1998. The International Life Sciences Institute's role in the evaluation of alternative methodologies for the assessment of carcinogenic risk. Toxicol. Pathol. 26: 474-475.
30. Rosenberg, R. N., Prusiner, S. B., DiMauro, S., Barchi, R. L. and Kunkel, L. M. 1993. The Molecular and Genetic Basis of Neurological Disease, Butterworth-Heinemann, Boston.
31. Saitoh, A., Kimura, M., Takahashi, R., Yokoyama, M., Nomura, T., Izawa, M., Sekiya, T., Nishimura, S. and Katsuki, M. 1990. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5: 1195-1200.
32. Sakamoto, A., Ono, K., Abe, M., Jasmin, G., Eki, T., Murakami, Y., Masaki, T., Toyo-oka, T. and Hanaoka, F. 1997. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc. Natl. Acad. Sci. U.S.A. 94: 13873-13878.
33. Shafiq, S. A., Askanas, V. and Milhorat, A. T. 1971. Fiber types and preclinical changes in chicken muscular dystrophy. Arch. Neurol. 25: 560-571.
34. Somlyo, A. V., Gonzalez-Serratos, H. G., Shuman, H., McClellan, G. and Somlyo, A. P. 1981. Calcium release and ionic changes in the sarcoplasmic reticulum of tetanized muscle: an electron-probe study. J. Cell. Biol. 90: 577-594.
35. Suemizu, H., Muguruma, K., Maruyama, C., Tomisawa, M., Kimura, M., Hioki, K., Shimozawa, N., Ohnishi, Y., Tamaoki, N. and Nomura, T. 2002. Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing. Mol. Carcinog. 34: 1-9.
36. Tanabe, Y., Woo, M. and Nonaka, I. 1991. X chromosome-linked muscular dystrophy (mdx) of the skeletal muscle, mouse, pp. 149-155. In: Cardiovascular and Musculoskeletal Systems (Jones, T. C., Mohr, U. and Hunt, R. D. eds.), Springer-Verlag, Berlin.
37. Tsuchiya, T., Kobayashi, K., Sakairi, T., Goto, K., Okada, M., Sano, F., Sugimoto, J., Morohashi, T., Usui, T. and Mutai, M. 2002. Skeletal myopathy in transgenic mice carrying human prototype c-Ha-ras gene. Toxicol. Pathol. 30: 501-506.
38. Uchino, M., Araki, S. and Yoshida, O. 1985. The mechanism of muscle fiber breakdown in Duchenne muscular dystrophy-with particular reference to the significance of opaque muscle fibers. Rinsho Shinkeigaku 25: 944-948.
39. Valentine, B. A., Winand, N. J., Pradhan, D., Moise, N. S., de Lahunta, A., Kornegay, J. N. and Cooper, B. J. 1992. Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review. Am. J. Med. Genet. 42: 352-356.
40. Watchko, J. F., O'Day, T. L. and Hoffman, E. P. 2002. Functional characteristics of dystrophic skeletal muscle: insights from animal models. J. Appl. Physiol. 93: 407-417.
41. Webster, C., Silberstein, L., Hays, A. P. and Blau, H. M. 1988. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52: 503-513.
42. Xu, H., Christmas, P., Wu, X. R., Wewer, U. M. and Engvall, E. 1994. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc. Natl. Acad. Sci. U.S.A. 91: 5572-5576.
43. Yamamoto, S., Urano, K., Koizumi, H., Wakana, S., Hioki, K., Mitsumori, K., Kurokawa, Y., Hayashi, Y. and Nomura, T. 1998. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ. Health Perspect. 106 (Suppl. 1): 57-69.